| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_af4a3a9b98305f14a213969a3222c6bd |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-46 |
| filingDate |
2020-11-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_39db217ee17f38adfee493f227a0cb24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7cca9262cd554489518223afad536caf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1308ec24fa0806856f57dc9603da32da
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0eef828b8214b831adcc07607de1e1fc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f638584eef37dbffd2a5cd0eddda4091
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_24024ebdffaa584c4fba3ca6ae88fbee
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9de1518ca503b403a7ab16d42cfa3e7f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_baa3bf37865355689fe0195c2a5b0c8d |
| publicationDate |
2022-05-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
RO-135710-A2 |
| titleOfInvention |
CONTROLLED 3D RELEASE PLATFORM FOR CANCER THERAPY |
| abstract |
The invention relates to a process for obtaining a 3D platform with controlled release of drugs for cancer therapy. The process according to the invention consists in the steps of generating an initial nanohydrogel-type platform consisting of chemically modified fibroin nanoparticles, loading with a 5-fluorouracil anti-tumor drug by immersion in a drug solution with concentrations of 2. ..6% by mass relative to the nanohydrogel mass, the introduction of nanohydrogel-type platforms into chitosan capsules and the sealing of the capsule with vinyl alcohol, resulting in a final 3 D-type controlled-release capsule platform for oral administration. |
| priorityDate |
2020-11-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |